Back
to sessions
Sep 29
Quick Pitch
QP 25 - Clinical Potpourri: Navigating Early-Stage RT, N1mi Disease, and Risk Mitigation in Triple Negative and HER2+ Breast Cancer
MODERATOR(S)
Neil Taunk, MD, MS - University of Pennsylvania
Eileen Connolly, MD, PhD - New York Presbyterian Hospital Columbia Campus
Credits
| AMA PRA Category 1 Credits: | 1.00 |
Presentations
-
05:00pm - 05:05pm ETSpeaker: Eileen Connolly, MD, PhD - New York Presbyterian Hospital Columbia Campus, New York
-
05:05pm - 05:10pm ET
-
05:10pm - 05:15pm ET
Adjuvant Endocrine Therapy Adherence and Outcomes in Early Breast Cancer Patients Treated With APBI: A Retrospective Analysis Stratified by LUMINA Criteria
Speaker: John Wilson V, BS - University of South Florida, Tampa -
05:15pm - 05:20pm ET
Local Recurrence Risk in Patients with Microinvasive vs. Early-stage Invasive Breast Cancer: Long Term Outcomes from a Multi-institutional Series
Speaker: Camille Hardy Abeloos, MD - NYU Grossman School of Medicine, New York -
05:20pm - 05:25pm ET
Validated Nomogram Tool Predicting Individualized Risks of Invasive Disease Recurrence for Breast Cancer Patients with N1mic Treated with and without Nodal Radiotherapy
Speaker: George Naoum, MD, MS - Memorial Sloan Kettering Cancer Center, New York -
05:25pm - 05:30pm ET
Post-Mastectomy Radiotherapy in pT1-2N1 HER2-Enriched Breast Cancer: Reassessing Its Role in the Anti-HER2 Era
Speaker: Xiaofang Wang, PhD - Fudan University Shanghai Cancer Center, Shanghai -
05:30pm - 05:35pm ET
Dosimetric Predictors of Pneumonitis In Patients with Localized HER2-Positive Breast Cancer Receiving Radiotherapy and Trastuzumab-Emtansine
Speaker: Hannah Bacon, MD, PhD - University of Toronto, Toronto -
05:35pm - 05:55pm ETSpeaker: Neil Taunk, MD, MS - University of Pennsylvania, Philadelphia
-
05:55pm - 06:00pm ETSpeaker: Eileen Connolly, MD, PhD - New York Presbyterian Hospital Columbia Campus, New York